Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

FRA/0VQ stock hub

FRA/0VQ has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/0VQis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

358.5M

Frankfurt Stock Exchange

Market data

Price

Recent price action with selectable time range.

FRA/0VQFRA/0VQ

—

Loading chart…

In the news

Latest news · FRA/0VQ

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-30.9

P25 n/aP50 n/aP75 n/a

ROIC-44.7

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/0VQ market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

157

Groups with data

Currency

USD

Showing 157 of 157 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United Kingdom
Country code	DE
Employees	56
Employees Change	-34%
Employees Change Percent	-37.78
Enterprise value	EUR 279.4M
Exchange	Frankfurt Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	EUR 358.5M
Price	EUR 1.45
Price currency	EUR
Rev Per Employee	70,858.39x
Sic	2836
Symbol	fra/0VQ
Website	https://www.puretechhealth.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-26.07%
EV Earnings	-2.99x
EV/FCF	-3.85x
EV/Sales	69.73x
FCF yield	-20.23%
P/B ratio	1.38x
P/S ratio	90.33x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	100%
Gross Profit	EUR 4M
Net Income	EUR -93.5M
Pretax Margin	-2,380.9%
Profit Per Employee	EUR -1.7M
ROA	-10.83
Roa5y	-12.32
ROCE	-20.17
ROE	-30.85
Roe5y	-10.87
ROIC	-44.74
Roic5y	-63.74

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-3.34%
Cagr3y	-15.87%
Cagr5y	-19.91%
Revenue Growth	-3.5x
Revenue Growth Q	542.71x
Revenue Growth3 Y	115.12x
Revenue Growth5 Y	-16.87x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.01
Assets	EUR 455.4M
Cash	EUR 245.9M
Current Assets	EUR 292M
Current Liabilities	EUR 34.4M
Debt	EUR 173.1M
Debt Equity	EUR 0.66
Debt FCF	EUR -2.39
Equity	EUR 260.3M
Interest Coverage	-2.15
Liabilities	EUR 195.1M
Long Term Assets	EUR 163.4M
Long Term Liabilities	EUR 160.7M
Net Cash	EUR 72.8M
Net Cash By Market Cap	EUR 20.31
Net Cash Growth	-52.85%
Net Debt Equity	EUR -0.28
Tangible Book Value	EUR 265.3M
Tangible Book Value Per Share	EUR 1.12

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	6.59
Net Working Capital	EUR -7M
Quick ratio	6.41
Working Capital	EUR 220.3M
Working Capital Turnover	EUR 0.01

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	6.38%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-3.33%
200-day SMA	1.44
3Y total return	-40.45%
50-day SMA	1.39
50-day SMA vs 200-day SMA	50under200
5Y total return	-67.05%
All Time High	5
All Time High Change	-71%
All Time High Date	2021-03-02
All Time Low	1.16
All Time Low Change	25%
All Time Low Date	2025-04-10
ATR	0.05
Ch YTD	-3.97
High	1.45
High52	1.67
High52 Date	2025-06-12
High52ch	-13.17%
Low	1.45
Low52	1.18
Low52 Date	2025-09-19
Low52ch	22.88%
Ma50ch	4.09%
Price vs 200-day SMA	0.97%
RSI	51.19
RSI Monthly	41.86
RSI Weekly	51.55
Sharpe ratio	0.15x
Sortino ratio	0.37
Total Return	6.38%
Tr YTD	-3.97
Tr1m	14.17%
Tr1w	-8.23%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -83.9M
Operating margin	-2,114.7

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	169,577,767%
Net Borrowing	-3,034,856
Shares Insiders	3.56%
Shares Institutions	77.93%
Shares Qo Q	-1%
Shares Yo Y	-6.38%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -79.5M
Average Volume	236.9x
Bv Per Share	1.12
CAPEX	EUR -5,110
Ch1m	14.17
Ch1w	-8.23
Ch1y	-3.33
Ch3y	-40.45
Ch5y	-67.05
Ch6m	4.32
Change	0%
Change From Open	0
Close	1.45
Days Gap	0
Depreciation Amortization	2,838,976.8
Earnings Date	2026-04-29
EBIT	EUR -83.9M
EBITDA	EUR -81.1M
EPS	EUR -0.39
F Score	2
FCF	EUR -72.5M
FCF EV Yield	-25.95x
Financing CF	-5,389,558
Fiscal Year End	December
Founded	2,015
Income Tax	EUR -717,131
Investing CF	53,902,390
Is Primary Listing	0
Last Earnings Date	2026-04-29
Last Report Date	2025-06-30
Ma150	1.43
Ma150ch	1.26%
Ma20	1.46
Ma20ch	-0.75%
Net CF	-23,993,241
Next Earnings Date	2026-05-28
Open	1.45
Ppne	11,289,766.1
Price Date	2026-05-08
Ptbv Ratio	1.35
Relative Volume	3.12x
Revenue	3,968,070x
SBC By Revenue	176.48x
Share Based Comp	7,002,677
Tax By Revenue	-18.07x
Tr6m	4.32%
Volume	0

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does FRA/0VQ pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/0VQ stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/0VQ?

Insider, institutional, and short-interest positioning.

Institutional ownership

+77.9%

Share of float held by funds and institutions

Insider ownership

+3.6%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-6.4%

Negative means the company is buying back shares.

Technical

FRA/0VQ momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

51.2

Neutral momentum band

Price vs 200-day MA

+1.0%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.15

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/0VQ

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/0VQ stock rating?

fra/0VQ is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/0VQ analysis?

The full report lives at /stocks/fra/0VQ/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/0VQ?

The latest report frames fra/0VQ around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/0VQ page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.